Bufei Qingyu Granules Inhibit the Development of Systemic Sclerosis via Notch-1/Jagged-2 Signaling Pathway

Figure 1

Fingerprints of BQG samples in the positive (a) and negative (b) ion modes by UHPLC-Q-TOF/MS. Peak 1, Amygdalin; Peak 2, Paeonol; Peak 3, Schizandrol A; Peak 4, Dihydrotanshinone I; Peak 5, Cryptotanshinone; Peak 6, Schizandrin A; Peak 7, Tanshinone IIA; Peak 8, Schizandrin B; Peak 9, Danshensu; Peak 10, Acteoside; Peak 11, Ferulic acid; Peak 12, Lobetyolin; Peak 13, Platycodin D; Peak 14, Astragaloside IV.

(a)

(b)